MedTrace Logo

Augmenting the Effects of Mirror Therapy for Stroke Rehabilitation by tDCS

NCT04655209 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2021-01-11

No results posted yet for this study

Summary

This project is to evaluate and compare the impact of tDCS stimulation location on augmenting MT effects.

Conditions

  • Cerebrovascular Accident

Interventions

BEHAVIORAL

apply a-tDCS on the ipsilesional M1 followed by MT (M1-Seq)

The participants in the M1-Seq group will first receive a-tDCS over ipsi-lesional M1 without any active arm practice for 20 minutes. For the next 20 minutes, the participants will start the MT, while the electrodes will be remained on the scalp with the stimulator off (sham tDCS condition). Then the electrodes will be removed, and the participants will receive additional 20 minutes of MT without tDCS followed by 30 minutes of functional task practice.

BEHAVIORAL

apply a-tDCS on the ipsilesional PMC followed by MT (PMC-Seq)

The procedures for the PMC-Seq group will be the same as the M1-Seq, except that a-tDCS will be applied on ipsilesional PMC but not M1.

BEHAVIORAL

MT only with sham tDCS (MT)

For the MT group, the procedure will be the same as the other groups except that sham tDCS will be used for the first 40 minutes.

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Principal Investigators

  • Ching-Yi Wu · Chang Gung University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-04
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04655209 on ClinicalTrials.gov